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Abstract
Background:  VIPomas are rare neuroendocrine tumors poorly described in the literature.
Aggressive resection of patients with advanced VIPoma neuroendocrine tumors has rarely been
reported.
Case presentation: A 46 year old women presented with abdominal pain and diarrhea. A three-
dimensional (3-D) pancreas protocol computed tomography scan revealed an 18 × 12 cm
pancreatic VIPoma abutting the liver, stomach, spleen, left adrenal, colon that also invaded the distal
duodenum – proximal jejunum at the ligament of Treitz in association with sinistral portal
hypertension. Following preoperative proximal splenic artery embolization, the patient with
underwent successful en bloc resection of the locally advanced VIPoma in conjunction with a
diaphragmatic resection, total gastrectomy, splenectomy, left adrenalectomy, as well as small and
large bowel resection. The estimated blood loss was 500 ml. All margins were negative (R0
resection). The patient is alive and disease-free.
Conclusion: This case illustrates the role of aggressive resection of pancreatic neuroendocrine
tumors and highlights several key technical points that allowed for successful resection.
Background
VIPomas are rare neuroendocrine tumors with an annual
incidence of about 1 per 10,000,000 individuals.[1] The
majority of VIPomas in adults (> 90%) are primary
tumors of the pancreas.[2] As with other neuroendocrine
tumors of the pancreas, on occasion these lesions can be
exceptionally large with invasion of adjacent visceral and
vascular structures. As such, accurate preoperative imaging
is critical. In particular, assessment of the relationship
between the tumor and adjacent vascular structures, such
as the portal and superior mesenteric vein (SMV) as well
as the celiac and superior mesenteric artery (SMA), is crit-
ical in determining preoperative resectability. On occa-
sion, invasion of the tumor into the adjacent splenic-
portal venous system can lead to sinistral, or left-sided,
portal hypertension.
Surgical resection of pancreatic VIPoma provides the only
chance at long-term cure, as systemic chemotherapeutic
agents are associated with poor response rates.[3] Never-
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theless, aggressive resection in patients with advanced
VIPoma neuroendocrine tumors has rarely been reported.
While part of the reason for this undoubtedly is due to the
rarity of VIPomas, another factor may be related to the
reluctance to perform aggressive resection due to possible
increased morbidity and mortality.[4] With careful atten-
tion to pre- and intra-operative details, aggressive resec-
tion of VIPomas can be accomplished safely, thereby
providing the patient with an opportunity for extended
long-term survival. We herein report a case of multi-vis-
ceral resection of pancreatic VIPoma in a patient with sin-
istral portal hypertension. Furthermore, we provide a brief
review of the role of aggressive resection of pancreatic
neuroendocrine tumors and highlight several key techni-
cal points that allowed for successful resection.
Case presentation
A 46-year-old obese woman presented to an outside hos-
pital in August of 2005 with significant abdominal pain
and diarrhea. Computed tomography (CT) revealed a 17
× 13 cm mass in the left upper quadrant that appeared to
arise from the body and tail of the pancreas. The patient
was taken to the operating room at an outside institution,
but the mass was deemed unresectable due to reported
involvement of the SMA, stomach, and colon. Wedge
biopsy of the mass was consistent with pancreatic
VIPoma. Over the next 2 years, the patient was treated
with long-acting somatostatin with some improvement in
her symptoms. The patient, however, developed repeat
episodes of upper and lower gastrointestinal bleeding
with associated anemia and ongoing transfusion require-
ments. Repeat CT scan revealed thrombosis of the splenic
vein with numerous large splenic and gastric varices con-
sistent with sinistral portal hypertension. In the summer
of 2007, the patient underwent a failed transjugular intra-
hepatic portosystemic shunt (TIPS) procedure at an out-
side institution. The patient was therefore referred to the
Johns Hopkins Department of Interventional Radiology
for variceal embolization.
The patient's case was reviewed at the Johns Hopkins
multi-disciplinary pancreas tumor board. A repeat three-
dimensional (3-D) pancreas protocol CT scan revealed an
18 × 12 cm mass abutting the liver, stomach, spleen, left
adrenal, colon and invading the distal duodenum – prox-
imal jejunum at the ligament of Treitz. The splenic vein
was occluded. Large collateral vessels surrounded the
mass and were associated with extensive gastric collaterals
(Figure 1). The mass displaced the SMA and SMV, but
these vessels were patent and uninvolved (Figure 2). As
such, there were no obvious contraindications to resec-
tion and surgery was recommended.
Given the size of the mass and the associated extensive
varices, the patient underwent preoperative proximal
splenic artery embolization (Figure 3). Twenty-four hours
following this, the patient was taken to surgery where she
was found to have a very large mass arising from the body
and tail of the pancreas that invaded the left diaphragm,
stomach, left adrenal, fourth portion of the duodenum –
first portion of the jejunum, transverse colon, and spleen.
In order to better expose the SMV at the inferior border of
the pancreatic neck, the right colon and root of the small
bowel mesentery were mobilized in the fashion of Cattell
(A) 3-D CT coronal reconstruction showing the pancreatic VIPoma, a large peri-tumoral varix, and gastric varices Figure 1
(A) 3-D CT coronal reconstruction showing the pancreatic VIPoma, a large peri-tumoral varix, and gastric 
varices. (B) 3-D CT coronal reconstruction depicting relation of pancreatic VIPoma to adjacent vascular structures and stom-
ach. Note presence of varices as well as invasion of tumor into the fourth portion of the duodenum.World Journal of Surgical Oncology 2008, 6:80 http://www.wjso.com/content/6/1/80
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and Braasch. The SMA medial to the SMV was exposed as
it coursed into the small bowel mesentery. The tumor was
noted to closely abut and displace both the SMV and SMA,
but the vessels were not encased. After developing the
retro-pancreatic plane over the SMV – portal vein, the pan-
creatic neck was transected. The mass was subsequently
resected en bloc with a portion of the left diaphragm,
entire stomach, spleen, left adrenalectomy, fourth portion
of the duodenum – proximal jejunum and transverse
colon. Gastrointestinal continuity was restored using a
Roux-en-Y method with a hand sewn end-to-side
esophago-jejunostomy, a duodeno-jejuneal anastomsis
(50 cm distally), and a stapled colo-colonic anastomosis.
The pancreatic remnant was closed with pledgeted
sutures. Estimated blood loss was 500 ml. Final pathology
confirmed a VIPoma originating from the pancreatic body
with invasion of the stomach, spleen, small bowel, and
colon (Figure 4). All margins were uninvolved by tumor.
The patient is alive and disease-free.
The patient tolerated the procedure well. On post-opera-
tive day four, a swallow study demonstrated a normal
post-surgical esophago-jejunal anastomosis with no evi-
dence of leak. The patient was discharged home on post-
operative day ten tolerating a post-gastrectomy diet. She
received no adjuvant therapy and is currently alive and
disease-free at 6 months of follow-up.
Discussion
VIPomas are rare tumors that have been infrequently
reported in the literature.[5] These pancreatic tumors
secrete excessive amounts of VIP (Vasoactive Intestinal
Peptide), a structural homologue of secretin. Elevated
serum VIP levels cause increased intestinal secretion of
Na+, K+, HCO3
-, and Cl-, as well as bone resorption,
vasodilation, and inhibition of gastric acid section. These
effects lead to a well-defined clinical syndrome, character-
ized by watery diarrhea, hypokalemia, and hypochlorhy-
dria. Despite this, the VIPoma syndrome can be difficult
to diagnosis and these tumors can elude prompt diagno-
sis.[5] As such, similar to other neuroendocrine tumors,
VIPomas can be quite large at the time of presentation and
involve adjacent structures. As in the current case, locore-
gional extension can include invasion into visceral struc-
tures. However, with an aggressive surgical approach that
allows for complete tumor extirpation, extended, mean-
ingful survival can be achieved for VIPoma patients.[5]
Cross-sectional CT depiction of large necrotic pancreatic VIPoma and its relation to the portal vein and superior mesenteric  artery Figure 2
Cross-sectional CT depiction of large necrotic pancreatic VIPoma and its relation to the portal vein and supe-
rior mesenteric artery.World Journal of Surgical Oncology 2008, 6:80 http://www.wjso.com/content/6/1/80
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Norton et al.,[4] have reported that aggressive surgery can
be done with acceptable morbidity and low mortality
rates for patients with advanced neuroendocrine tumors.
In a series of 20 patients with advanced tumors, Norton et
al.,[4] reported a post-operative complication rate of 30%
and no operative deaths. In that study, surgery variably
included pancreatectomy, splenectomy, superior vein
reconstruction, and liver resection. In the current case, the
patient underwent an extensive procedure that included
pancreatectomy, splenectomy, total gastrectomy, left
adrenalectomy, diaphragmatic resection, as well as small
and large bowel resection. An R0 resection (microscopi-
cally negative margins) was achieved and the patient did
well post-operatively. Patients with locally advanced neu-
roendocrine tumors that can be technically resected with
an R0 margin should therefore be offered surgical resec-
tion even when a multi-visceral resection is necessary. In
high-volume institutions, these procedures can be accom-
plished with acceptable morbidity and near-zero mortal-
ity.[4,6,7]
Accurate CT imaging is critical in assessing locoregional
resectability.[8,9] Recently, 3-D CT scan has been reported
to enhance the assessment of the tumor-vascular inter-
face,[10] as the 3-D format allows for better viewing of
oblique orientations.[11] Accurate information concern-
ing the relation of the tumor with the SMA is particularly
critical as major arterial encasement may preclude an R0
resection. It is important to note, however, that intraoper-
ative assessment of the tumor-SMA relationship can be
very limited – especially in patients with large tumors.[12]
This is evidenced in the current case in which the initial
surgeon deemed the lesion to be unresectable based on an
intraoperative assessment that the SMA was encased.
Celiac axis arteriogram depicting normal arterial anatomy and presence of interlock embolization coils used to embolize the  proximal splenic artery preoperatively Figure 3
Celiac axis arteriogram depicting normal arterial anatomy and presence of interlock embolization coils used 
to embolize the proximal splenic artery preoperatively.World Journal of Surgical Oncology 2008, 6:80 http://www.wjso.com/content/6/1/80
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High-quality cross-sectional imaging clearly demon-
strated, however, that the SMA was indeed not involved
(Figure 3). This case highlights how intraoperative assess-
ment of the tumor-SMA interface may be both limited and
misleading. Rather, thin-section contrast-enhanced CT
should be utilized as the modality of choice in assessing
the relationship of the primary tumor to major vascular
structures such as the SMV, PV, SMA, and celiac axis. Such
determinations have important clinical implications in
deciding which patients are candidates for aggressive
resection of advanced pancreatic tumors.
For tumors such as the one presented here, the surgeon
should still evaluate the SMV and SMA early in the course
of surgery. Full exposure of the SMV is mandatory and
requires mobilization of the colon and root of the small
bowel mesentery to expose the SMV where it lies anterior
to the third portion of the duodenum. This mobilization
should be carried to the left by incising the omental
attachment to the mesocolon. After performing a wide
Kocher maneuver, the SMA should similarly be identified
at the junction of the third and fourth portions of the duo-
denum as it courses distally. The connective tissue attach-
ments between the portal vein/SMV and SMA can then be
divided, thereby isolating the vessels. This "medial"
approach allows for early dissection and evaluation of the
critical vascular structures. Once the relation of the tumor
to these structures has been established, more lateral dis-
section along the spleen and tail of the pancreas can be
accomplishing with little difficulty. This method of dis-
secting the SMA and SMV first allows the surgeon to avoid
committing to an extensive resection prior to determining
whether or not an R0 resection is feasible.[13]
Sinistral, or left-sided, portal hypertension rarely causes
gastrointestinal hemorrhage. Although there are many
causes of sinistral hypertension, it is usually due to pan-
creatic pathology that compresses/invades the left portal –
splenic venous system.[14,15] Splenic vein occlusion
results in back pressure which is transmitted to the short
gastric and gastroepiploic veins with subsequent forma-
tion of varices. Our patient had extensive gastric and peri-
tumoral varices that were associated with ongoing bleed-
ing and transfusion requirements. Management of sinis-
tral hypertension traditionally involves surgical removal
of the primary tumor if possible. In the current case,
although resection was deemed to be feasible, the risk of
intra-operative massive hemorrhage was felt to be consid-
erable given the extent of the varices, as well as the size
and location of the primary pancreatic mass. Preoperative
proximal splenic artery embolization has previously been
shown to be a safe and efficacious portal decompression
technique.[16,17] Umeda et al., [17] have shown that
proximal splenic artery embolization shortened operative
time, reduced blood loss, and led to less need for transfu-
sion in living donor liver transplantation recipients. In a
separate study, Adams and colleagues[16] assessed the
benefit of preoperative control of splenic arterial inflow
on intraoperative blood loss in a cohort of patients with
splenic venous occlusion and sinistral hypertension sec-
ondary to chronic pancreatitis. In this study, the mean
reduction in blood loss associated with embolization was
1560 ml. The employment of preoperative proximal
(A) Typical of pancreatic neuroendocrine tumors, this lesion contains interconnecting nests and trabeculae of uniform cuboi- dal cells with granular cytoplasm and central round nuclei within a hyalinized, well-vascularized stroma (Original magnification  ×100) Figure 4
(A) Typical of pancreatic neuroendocrine tumors, this lesion contains interconnecting nests and trabeculae of 
uniform cuboidal cells with granular cytoplasm and central round nuclei within a hyalinized, well-vascularized 
stroma (Original magnification ×100). (B) The tumor deeply invades the muscularis propria of the stomach (Original 
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splenic artery embolization in the present case undoubt-
edly contributed to our relatively modest blood loss
(~500 ml). In complex cases characterized by large
tumors, splenic vein occlusion, and significant left-side
portal hypertension with associated varices, preoperative
embolization of the proximal splenic artery should be
considered to allow for portal decompression as a means
to reduce intraoperative blood loss. Preoperative splenic
artery embolization should be used selectively, however,
as it may have associated risks.[18]
Conclusion
The current case is a unique example of a rare pancreatic
tumor (VIPoma) that highlights several important peri-
and intra-operative concepts. Aggressive resection of
VIPomas is warranted and may provide the only chance at
long-term survival. When done at large volume, experi-
enced centers even complex multi-visceral resections can
be done with low morbidity and near zero morality. In the
subset of patients with associated severe sinistral hyper-
tension, proximal splenic artery embolization should be
considered as a preoperative means to decrease blood loss
and improve outcome. Only by utilizing a multi-modality
approach that incorporates state-of-art cross-sectional
imaging, interventional radiology, and surgery can these
complex patients be managed successfully.
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